Literature DB >> 9143942

HIV-1 recombinant gp41 induces IL-10 expression and production in peripheral blood monocytes but not in T-lymphocytes.

A Koutsonikolis1, S Haraguchi, E N Brigino, U E Owens, R A Good, N K Day.   

Abstract

The effects of recombinant gp41 (rgp41) protein of the human immunodeficiency virus type 1 (HIV-1) on interleukin 10 (IL-10) expression and production using human peripheral blood mononuclear cells was investigated. Expression of IL-10 mRNA was demonstrated within 3 h of cell exposure to endotoxin-free rgp41 by RT-PCR and Northern blot analyses in a time- and dose-dependent manner. IL-10 protein was detected in the supernatants of peripheral blood mononuclear cells following stimulation with rgp41 also in a dose dependent manner. Fractionation of peripheral blood mononuclear cells showed that purified monocytes but not purified T-lymphocytes induced expression of IL-10 mRNA by rgp41. Recombinant HIV-1 gp120 exhibits similar influences on the induction of IL-10. These results indicate that both of these components of envelope proteins may play an important role in HIV related immunomodulation by influencing regulatory functions of monocytes and macrophages.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9143942     DOI: 10.1016/s0165-2478(97)02695-3

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  7 in total

1.  HIV-1 envelope gp41 is a potent inhibitor of chemoattractant receptor expression and function in monocytes.

Authors:  H Ueda; O M Howard; M C Grimm; S B Su; W Gong; G Evans; F W Ruscetti; J J Oppenheim; J M Wang
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

2.  Gp-41-mediated astrocyte inducible nitric oxide synthase mRNA expression: involvement of interleukin-1beta production by microglia.

Authors:  S Hu; H Ali; W S Sheng; L C Ehrlich; P K Peterson; C C Chao
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

3.  Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage.

Authors:  Woong-Ki Kim; Yue Sun; Hien Do; Patrick Autissier; Elkan F Halpern; Michael Piatak; Jeffrey D Lifson; Tricia H Burdo; Michael S McGrath; Kenneth Williams
Journal:  J Leukoc Biol       Date:  2009-10-20       Impact factor: 4.962

4.  Modulation of cytokine release and gene expression by the immunosuppressive domain of gp41 of HIV-1.

Authors:  Joachim Denner; Magdalena Eschricht; Michael Lauck; Marwan Semaan; Philipp Schlaermann; Hyunmi Ryu; Levent Akyüz
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

5.  Single mutations in the transmembrane envelope protein abrogate the immunosuppressive property of HIV-1.

Authors:  Vladimir A Morozov; Alexey V Morozov; Marwan Semaan; Joachim Denner
Journal:  Retrovirology       Date:  2012-08-13       Impact factor: 4.602

6.  Antigenic and immunosuppressive properties of a trimeric recombinant transmembrane envelope protein gp41 of HIV-1.

Authors:  Michael Mühle; Melissa Lehmann; Kerstin Hoffmann; Daniel Stern; Tobias Kroniger; Werner Luttmann; Joachim Denner
Journal:  PLoS One       Date:  2017-03-10       Impact factor: 3.240

7.  Absence of IL-10 production by human PBMCs co-cultivated with human cells expressing or secreting retroviral immunosuppressive domains.

Authors:  Daniel Ivanusic; Heiko Pietsch; Jasper König; Joachim Denner
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.